N
The startup develops allosteric modulator therapies that target receptors outside the active site to treat neurological disorders. Its drug discovery platform enhances the efficacy, safety, and tolerability of treatments for patients with underserved neurological conditions.
Geneva, United States
Updated 2 months ago
Funding
$65M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops allosteric modulator therapies that target receptors outside the active site to treat neurological disorders. Its drug discovery platform enhances the efficacy, safety, and tolerability of treatments for patients with underserved neurological conditions.